Correlation Between Emergent Biosolutions and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and Akari Therapeutics PLC, you can compare the effects of market volatilities on Emergent Biosolutions and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Akari Therapeutics.
Diversification Opportunities for Emergent Biosolutions and Akari Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Emergent and Akari is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Emergent Biosolutions and Akari Therapeutics
Considering the 90-day investment horizon Emergent Biosolutions is expected to generate 0.55 times more return on investment than Akari Therapeutics. However, Emergent Biosolutions is 1.81 times less risky than Akari Therapeutics. It trades about 0.3 of its potential returns per unit of risk. Akari Therapeutics PLC is currently generating about 0.16 per unit of risk. If you would invest 806.00 in Emergent Biosolutions on October 20, 2024 and sell it today you would earn a total of 182.00 from holding Emergent Biosolutions or generate 22.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Emergent Biosolutions vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Emergent Biosolutions |
| Akari Therapeutics PLC |
Emergent Biosolutions and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Emergent Biosolutions and Akari Therapeutics
The main advantage of trading using opposite Emergent Biosolutions and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |